Russian Federation

Emergency contraception (EC) is available in the Russian Federation: LNG EC and mifepristone EC pills are available from pharmacies and family planning clinics, and LNG EC is included in the national contraceptives guide, but EC is not reimbursed or covered by social security.

Sexual & reproductive health background information

Female population aged 15-49 Mean age at first sexual intercourse Mean age at birth of first child Total fertility rate % use of modern contraceptive methods
Estimate 35,038,0001 n/a 24.62 1.293 65.0%4
Year 2015 n/a 2009 2005 2007

Accessibility & prescription status

In the Russian Federation, LNG EC and mifepristone EC pills are available by prescription from pharmacies and family planning clinics. UPA EC is not registered. Although a prescription is mandatory in order to purchase LNG EC and all types of hormonal contraceptives, anecdotal data suggests that EC pills can often be obtained without a prescription from pharmacies and that UPA EC can be obtained from neighboring countries via the Internet.

Physicians are the sole health care professionals who are authorized to prescribe EC pills.

Cost

Type of EC Approximate Cost Brand(s) Available
LNG € 7,55 Escapelle, Escinor, Postinor
Mifepristone € 7 – 10 Gynepriston

The cost of LNG EC and mifepristone EC pills is not reimbursed or covered by social security in the Russian Federation.

Guidelines & common practices

“The Russian Federation National Medical Criteria for Contraceptive Use,” published in 2012, includes information on EC among other contraceptive methods. Additionally, civil society organizations are working to strengthen knowledge of EC among health care providers and have developed a Russian version of the ICEC and FIGO EC guidelines Emergency Contraceptive Pills: Medical and Service Delivery Guidelines.

Health care providers sometimes provide general information about EC during regular consultations but rarely prescribe EC in advance of need. Health care providers also do not require a pregnancy test before prescribing EC.

EC use

Ever use of EC EC use in the last 12 months % with no prescription Repeated use of EC in last 12 months
Estimate n/a n/a n/a n/a
Year n/a n/a n/a n/a

 

Sources

1 United Nations Department of Economic and Social Affairs, Population Division. World Population Prospects: The 2012 Revision. New York, 2013.

2 United Nations Economic Commission for Europe Statistical Division Database. Mean Age of Women at Birth of First Child by Country and Year. Updated 23 November 2012. Retrieved 19 June 2013, from http://w3.unece.org/pxweb/dialog/varval.asp?ma=04_GEFHAge1stChild_r&path=../database/STAT/30-GE/02-Families_households/&lang=1&ti=Mean+age+of+women+at+birth+of+first+child.

European health for all database (HFA-DB), World Health Organization Regional Office for Europe. Total fertility rate. Retrieved 18 June 2013, from http://data.euro.who.int/hfadb/.

4 United Nations Department of Economic and Social Affairs, Population Division. World Contraceptive Use 2012. New York, 2012.

Last update: September 2013